Guangdong Jiaying Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.46%

Guangdong Jiaying Pharmaceutical Co Ltd (002198) has an Asset Resilience Ratio of 0.46% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥4.10 Million

≈ $599.28K USD Cash + Short-term Investments

Total Assets

CN¥892.78 Million

≈ $130.64 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Guangdong Jiaying Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Guangdong Jiaying Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Guangdong Jiaying Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002198 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥4.10 Million	0.46%
Total Liquid Assets	CN¥4.10 Million	0.46%

Asset Resilience Insights

Limited Liquidity: Guangdong Jiaying Pharmaceutical Co Ltd maintains only 0.46% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong Jiaying Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong Jiaying Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
AstraZeneca PLC NYSE:AZN	Drug Manufacturers - General	0.10%
Dimed S.A. Distribuidora de Medicamentos SA:PNVL3	Drug Manufacturers - General	7.83%
AstraZeneca PLC F:ZEGA	Drug Manufacturers - General	0.03%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	8.63%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.48%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%
Sichuan Kelun Pharmaceutical Co Ltd SHE:002422	Drug Manufacturers - General	4.41%

Annual Asset Resilience Ratio for Guangdong Jiaying Pharmaceutical Co Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Guangdong Jiaying Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.47%	CN¥12.47 Million ≈ $1.82 Million	CN¥849.23 Million ≈ $124.27 Million	-22.19pp
2023-12-31	23.66%	CN¥200.53 Million ≈ $29.34 Million	CN¥847.56 Million ≈ $124.03 Million	+17.72pp
2022-12-31	5.94%	CN¥50.26 Million ≈ $7.35 Million	CN¥846.65 Million ≈ $123.89 Million	+11.94pp
2019-12-31	-6.00%	CN¥-51.35 Million ≈ $-7.51 Million	CN¥855.94 Million ≈ $125.25 Million	-6.00pp
2018-12-31	0.00%	CN¥-12.83K ≈ $-1.88K	CN¥889.56 Million ≈ $130.17 Million	+0.04pp
2017-12-31	-0.04%	CN¥-326.08K ≈ $-47.72K	CN¥876.61 Million ≈ $128.28 Million	+0.38pp
2016-12-31	-0.42%	CN¥-4.58 Million ≈ $-670.90K	CN¥1.10 Billion ≈ $160.86 Million	--
2015-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥1.05 Billion ≈ $153.35 Million	--
2014-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥1.04 Billion ≈ $151.49 Million	--

pp = percentage points

About Guangdong Jiaying Pharmaceutical Co Ltd

SHE:002198 China Drug Manufacturers - General

Market Cap

$243.59 Million

CN¥1.66 Billion CNY

Market Cap Rank

#15685 Global

#4563 in China

Share Price

CN¥3.28

Change (1 day)

+1.55%

52-Week Range

CN¥2.96 - CN¥8.43

All Time High

CN¥14.97